The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists.
TAP Pharmaceuticals Inc., Abbott Laboratories, Abbott Park, Illinois 60064.
F
F
Haviv
T D
TD
Fitzpatrick
C J
CJ
Nichols
R E
RE
Swenson
N A
NA
Mort
E N
EN
Bush
G
G
Diaz
A T
AT
Nguyen
M R
MR
Holst
V A
VA
Cybulski
D000595:Amino Acid Sequence; D000818:Animals; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors*; D008781:Methyltyrosines / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D008969:Molecular Sequence Data; D010455:Peptides / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D011966:Receptors, LHRH / Q000378:metabolism; D013329:Structure-Activity Relationship
D008781:Methyltyrosines; D010455:Peptides; D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone